M42 Health
United Arab Emirates
17th June 2025
2506-1956-8
Overview
M42 was established in 2022 following the merger of G42 Healthcare and Mubadala Health. Since then, it has grown into a global leader, operating over 480 facilities across 26 countries with a workforce of more than 20,000 professionals committed to transforming healthcare.
M42’s Integrated Health Solutions (IHS) platform drives national programs and population health initiatives, tackling global health challenges through precision, prevention, and predictive care. Its flagship efforts include the Emirati Genome Program (EGP) for personalized healthcare, Abu Dhabi BioBank for drug discovery and biobanking, and Biogenix Labs, advancing precision medicine with Next-Generation Sequencing (NGS). Environmental Sciences analyzes non-human factors affecting public health, while IROS fosters innovation through high-quality clinical research, reinforcing M42’s commitment to a healthier, more sustainable future.
The Senior Manager plays a pivotal role in overseeing the strategy and operations of the Pan-human component of the Abu Dhabi Biobank, driving its economic and scientific growth, sustainability, and innovation. As the primary repository for biospecimens and associated data from volunteer participants, the Biobank is essential in advancing translational research, precision medicine, scientific discovery and commercialization. The Senior Manager will help define operational strategies, maximize asset utilization, and establish key performance indicators (KPIs) to ensure long-term success.
Responsibilities
| Role Level: | Mid-Level | Work Type: | Full-Time |
|---|---|---|---|
| Country: | United Arab Emirates | City: | Abu Dhabi |
| Company Website: | https://m42.ae/ | Job Function: | Healthcare Administration |
| Company Industry/ Sector: |
Hospitals and Health Care | ||
M42 is an Abu Dhabi-based, global tech-enabled healthcare company operating at the forefront of medical advancement. The company is seeking to transform lives through innovative clinical solutions that can solve the world’s most critical health and diagnostic challenges. By harnessing unique medical and data-centric technologies, including genomics and AI, M42 is transforming the traditional healthcare ecosystem and delivering the highest level of precise, patient-centric, and preventative care.M42 has over 20,000 employees and more than 450 facilities in 26 countries around the world. M42 owns a wide portfolio of assets that includes Amana Healthcare, Biogenix Labs, Danat Al Emarat, Diaverum, HealthPoint Hospital, the HealthPlus network of specialty centers, Moorfields Eye Hospital Abu Dhabi, Imperial College London Diabetes Centre, Insights Research Organization & Solutions (IROS), Omics Center of Excellence and National Reference Laboratory, among others.
Disclaimer: talentmate.com is only a platform to bring jobseekers & employers together. Applicants are advised to research the bonafides of the prospective employer independently. We do NOT endorse any requests for money payments and strictly advice against sharing personal or bank related information. We also recommend you visit Security Advice for more information. If you suspect any fraud or malpractice, email us at abuse@talentmate.com.